Invention Grant
- Patent Title: BSL3 polypeptides
- Patent Title (中): BSL3多肽
-
Application No.: US13331540Application Date: 2011-12-20
-
Publication No.: US08664360B2Publication Date: 2014-03-04
- Inventor: Glen Eugene Mikesell , Han Chang , Robert James Peach
- Applicant: Glen Eugene Mikesell , Han Chang , Robert James Peach
- Applicant Address: US NJ Princeton
- Assignee: Bristols-Myers Squibb Company
- Current Assignee: Bristols-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Stephen C. D'Amico
- Main IPC: C07K14/00
- IPC: C07K14/00

Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.
Public/Granted literature
- US20120329990A1 B7-RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION Public/Granted day:2012-12-27
Information query